Skip to main content
Clinical Trials/TCTR20130325001
TCTR20130325001CompletedPhase 3

A randomized comparative study of the efficacy on pupillary dilatation between separate bottles of dilating eye drops and a single-bottle eye drop mixture.

one0 sites28 target enrollmentStarted: March 25, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
one
Enrollment
28

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 0 N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • - age 18 or older
  • - clear cornea (pupil can be easily measured)
  • - patients with hypertension must have resting BP not more than 160/95 mmHg
  • - patient receives studied eye drops in only 1 eye

Exclusion Criteria

  • - pupil distortion or any congenital anomaly of pupil (such as corectopia)
  • - untreated appositional angle or angle closure
  • - pregnancy
  • - allergic to any of the study drugs
  • - patient who cannot complete the study

Investigators

Sponsor
one

Similar Trials